Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/7329
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPay, S.-
dc.contributor.authorÖztürk, M.A.-
dc.contributor.authorCan, G.-
dc.contributor.authorCefle, A.-
dc.contributor.authorÇobankara, Veli.-
dc.contributor.authorErer, B.-
dc.contributor.authorGö?üş, F.-
dc.date.accessioned2019-08-16T12:19:58Z
dc.date.available2019-08-16T12:19:58Z
dc.date.issued2008-
dc.identifier.issn1462-0324-
dc.identifier.urihttps://hdl.handle.net/11499/7329-
dc.identifier.urihttps://doi.org/10.1093/rheumatology/ken026-
dc.description.abstractAbstract Not Availableen_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofRheumatologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectadalimumaben_US
dc.subjectetanercepten_US
dc.subjectinfliximaben_US
dc.subjectantirheumatic agenten_US
dc.subjecttumor necrosis factor alphaen_US
dc.subjectadulten_US
dc.subjectankylosing spondylitisen_US
dc.subjectcancer risken_US
dc.subjectdrug substitutionen_US
dc.subjectdrug withdrawalen_US
dc.subjectfemaleen_US
dc.subjecthealth surveyen_US
dc.subjecthematologic malignancyen_US
dc.subjecthumanen_US
dc.subjectjuvenile rheumatoid arthritisen_US
dc.subjectletteren_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectpriority journalen_US
dc.subjectpsoriatic arthritisen_US
dc.subjectrheumatoid arthritisen_US
dc.subjectrisk assessmenten_US
dc.subjectrisk factoren_US
dc.subjectsolid tumoren_US
dc.subjectTurkey (republic)en_US
dc.subjectadolescenten_US
dc.subjectarthritisen_US
dc.subjectchemically induced disorderen_US
dc.subjectclinical trialen_US
dc.subjectdrug antagonismen_US
dc.subjectmiddle ageden_US
dc.subjectmulticenter studyen_US
dc.subjectneoplasmen_US
dc.subjectAdolescenten_US
dc.subjectAdulten_US
dc.subjectAntirheumatic Agentsen_US
dc.subjectArthritisen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectNeoplasmsen_US
dc.subjectRisk Assessmenten_US
dc.subjectTumor Necrosis Factor-alphaen_US
dc.titleRisk of cancer in Turkish patients after treatment with TNF antagonistsen_US
dc.typeLetteren_US
dc.identifier.volume47en_US
dc.identifier.issue4en_US
dc.identifier.startpage548
dc.identifier.startpage548en_US
dc.identifier.endpage549en_US
dc.authorid0000000312647971-
dc.identifier.doi10.1093/rheumatology/ken026-
dc.relation.publicationcategoryDiğeren_US
dc.identifier.scopus2-s2.0-43049166010en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.languageiso639-1en-
item.openairetypeLetter-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
Files in This Item:
File SizeFormat 
ken026.pdf128.52 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

8
checked on Jun 29, 2024

Page view(s)

8
checked on May 27, 2024

Download(s)

12
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.